Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.27)
# 3,471
Out of 4,854 analysts
784
Total ratings
31.16%
Success rate
-11.91%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHIO Phio Pharmaceuticals | Assumes: Buy | $14 | $2.96 | +372.97% | 1 | Jun 5, 2025 | |
| ATYR aTyr Pharma | Reiterates: Buy | $35 | $5.38 | +550.56% | 9 | Jun 4, 2025 | |
| ANL Adlai Nortye | Downgrades: Neutral | n/a | $1.65 | - | 4 | Jun 2, 2025 | |
| BLRX BioLineRx | Reiterates: Buy | $26 | $5.74 | +352.96% | 13 | May 28, 2025 | |
| XOMA XOMA Royalty | Reiterates: Buy | $104 | $25.25 | +311.88% | 24 | May 28, 2025 | |
| ARMP Armata Pharmaceuticals | Maintains: Buy | $7 → $9 | $1.98 | +354.55% | 15 | May 19, 2025 | |
| CRIS Curis | Assumes: Buy | $17 | $2.32 | +632.76% | 1 | May 19, 2025 | |
| CVKD Cadrenal Therapeutics | Reiterates: Buy | $32 | $15.10 | +111.92% | 6 | May 16, 2025 | |
| PHGE BiomX | Maintains: Buy | $21 → $15 | $0.47 | +3,097.61% | 15 | May 16, 2025 | |
| CALC CalciMedica | Reiterates: Buy | $16 | $1.76 | +809.09% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.31 | +3,091.83% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.83 | +118.58% | 30 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $2.05 | +875.61% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $50 | $21.35 | +134.19% | 33 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.97 | +827.84% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $136.94 | +75.26% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $2.49 | +622.89% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $15 | $8.94 | +67.79% | 9 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.73 | +494.35% | 26 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.75 → $4.5 | $1.00 | +350.00% | 22 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.63 | +688.89% | 16 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.22 | +1,211.48% | 28 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $27.83 | +266.51% | 32 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $2.50 | +860.00% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $32.30 | +271.52% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.38 | +624.64% | 2 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $8.25 | +94.04% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.14 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $4.25 | +629.41% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.47 | +2,437.00% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.77 | +421.72% | 21 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $13 | $1.69 | +669.23% | 30 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.14 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $11.88 | +211.45% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $14.23 | +441.11% | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.50 | +633.33% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $5.99 | +167.11% | 19 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.68 | +1,232.94% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $21.49 | +165.24% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $6.87 | +205.68% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.75 | +1,042.86% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.17 | +1,051.81% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.69 | +457.62% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $106.15 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $2.00 | +1,200.00% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.00 | +524.70% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.24 | +7,964.52% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.70 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.71 | +1,771.35% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.46 | +1,119.51% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.93 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $40.06 | -17.62% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.42 | +1,114.95% | 1 | Mar 24, 2017 |
Phio Pharmaceuticals
Jun 5, 2025
Assumes: Buy
Price Target: $14
Current: $2.96
Upside: +372.97%
aTyr Pharma
Jun 4, 2025
Reiterates: Buy
Price Target: $35
Current: $5.38
Upside: +550.56%
Adlai Nortye
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.65
Upside: -
BioLineRx
May 28, 2025
Reiterates: Buy
Price Target: $26
Current: $5.74
Upside: +352.96%
XOMA Royalty
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $25.25
Upside: +311.88%
Armata Pharmaceuticals
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $1.98
Upside: +354.55%
Curis
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $2.32
Upside: +632.76%
Cadrenal Therapeutics
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $15.10
Upside: +111.92%
BiomX
May 16, 2025
Maintains: Buy
Price Target: $21 → $15
Current: $0.47
Upside: +3,097.61%
CalciMedica
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $1.76
Upside: +809.09%
May 13, 2025
Reiterates: Buy
Price Target: $10
Current: $0.31
Upside: +3,091.83%
May 12, 2025
Reiterates: Buy
Price Target: $4
Current: $1.83
Upside: +118.58%
May 9, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $2.05
Upside: +875.61%
May 9, 2025
Maintains: Buy
Price Target: $80 → $50
Current: $21.35
Upside: +134.19%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.97
Upside: +827.84%
May 6, 2025
Reiterates: Buy
Price Target: $240
Current: $136.94
Upside: +75.26%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $2.49
Upside: +622.89%
Apr 30, 2025
Reiterates: Buy
Price Target: $11 → $15
Current: $8.94
Upside: +67.79%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $6.73
Upside: +494.35%
Apr 25, 2025
Maintains: Buy
Price Target: $5.75 → $4.5
Current: $1.00
Upside: +350.00%
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.63
Upside: +688.89%
Apr 25, 2025
Reiterates: Buy
Price Target: $16
Current: $1.22
Upside: +1,211.48%
Apr 24, 2025
Reiterates: Buy
Price Target: $102
Current: $27.83
Upside: +266.51%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $2.50
Upside: +860.00%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $32.30
Upside: +271.52%
Apr 14, 2025
Reiterates: Buy
Price Target: $10
Current: $1.38
Upside: +624.64%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $8.25
Upside: +94.04%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.14
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $4.25
Upside: +629.41%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.47
Upside: +2,437.00%
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.77
Upside: +421.72%
Mar 27, 2025
Maintains: Buy
Price Target: $21 → $13
Current: $1.69
Upside: +669.23%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $11.88
Upside: +211.45%
Mar 20, 2025
Reiterates: Buy
Price Target: $77
Current: $14.23
Upside: +441.11%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.50
Upside: +633.33%
Mar 11, 2025
Reiterates: Buy
Price Target: $16
Current: $5.99
Upside: +167.11%
Mar 11, 2025
Reiterates: Buy
Price Target: $9
Current: $0.68
Upside: +1,232.94%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $21.49
Upside: +165.24%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $6.87
Upside: +205.68%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.75
Upside: +1,042.86%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.17
Upside: +1,051.81%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.69
Upside: +457.62%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $106.15
Upside: -
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $2.00
Upside: +1,200.00%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $4.00
Upside: +524.70%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.24
Upside: +7,964.52%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.70
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.71
Upside: +1,771.35%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.46
Upside: +1,119.51%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.93
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $40.06
Upside: -17.62%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.42
Upside: +1,114.95%